中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects

文献类型:期刊论文

作者Hua, Chao1; Chen, Chen1,2; Yu, Xiaolu1,2,3; Li, Zhiying1; Tang, Feng1; Sun, Qi1,4; Long, Yiru1,2; Gong, Likun1,2,5
刊名ACTA PHARMACEUTICA SINICA B
出版日期2025-07-01
卷号15期号:7页码:3819-3823
ISSN号2211-3835
DOI10.1016/j.apsb.2025.05.005
资助项目National Natural Science Foundation of China[82341039] ; Science and Technology Innovation Action Plan of Shanghai (China)[22S11902100] ; National Key Research and Development Plan (China)[2022YFC2304105] ; Shanghai Postdoctoral Excellence Program (China)[2023699] ; Postdoctoral Fellowship Program of CPSF (China)[GZB20230797]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:001533878600001
出版者INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
源URL[http://119.78.100.183/handle/2S10ELR8/321105]  
专题国家级研究中心_原创新药研究全国重点实验室
通讯作者Long, Yiru; Gong, Likun
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
3.China Med Univ, Sch Publ Hlth, Shenyang 110122, Peoples R China
4.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China
5.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528400, Peoples R China
推荐引用方式
GB/T 7714
Hua, Chao,Chen, Chen,Yu, Xiaolu,et al. Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects[J]. ACTA PHARMACEUTICA SINICA B,2025,15(7):3819-3823.
APA Hua, Chao.,Chen, Chen.,Yu, Xiaolu.,Li, Zhiying.,Tang, Feng.,...&Gong, Likun.(2025).Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects.ACTA PHARMACEUTICA SINICA B,15(7),3819-3823.
MLA Hua, Chao,et al."Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects".ACTA PHARMACEUTICA SINICA B 15.7(2025):3819-3823.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。